Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-10-15, the close was $295.54: 4.4% below the 50-day average and 1.4% below the 200-day average, which is rising. RSI (14) is 49, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 70% of the way up its 52-week range of $183.30 to $342.75, on 0.7x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $309.17 | Price 4.4% below |
| 200-day average | $299.68 | Price 1.4% below, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 49 | Neutral range |
| MACD (12, 26, 9) | -4.28 vs -5.94 | Bullish cross in the last 10 days |
| 52-week range | $183.30 to $342.75 | 70% of the way up the range |
| Volume vs 20-day average | 0.7x | Normal |
Base rates use FDX's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-15, FDX's 14-day RSI is 49, which is in the neutral range between 30 and 70.
No. FDX closed at $295.54 on 2026-10-15, 1.4% below its 200-day average of $299.68, which is rising. When it closed below its 200-day average (2,461 days), it was higher 63 trading days later 57% of the time, median +3.1%.
No. FDX closed at $295.54 on 2026-10-15, 4.4% below its 50-day average of $309.17. When it closed below its 50-day average (2,831 days), it was higher 63 trading days later 61% of the time, median +3.3%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-15 the MACD line is -4.28 against a signal line of -5.94, so MACD is bullish.
No. At $295.54 it sits 70% of the way up its 52-week range of $183.30 to $342.75, 13.8% below the high.
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-10-15 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bullish, from the chart signal model.
FDX analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.